BX005-A

· BiomX, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BX005-A, covering 2025-08-03 to 2025-08-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis [Phase 1, Phase 2]